Therapy for rare bone disorder shows promise in clinical trial
A clinical trial at the National Institutes of Health found that a medication, denosumab, significantly reduced abnormal bone turnover in adults with fibrous dysplasia, a rare disease marked by weak and misshapen bones. Bone ...
Apr 5, 2023
0
57
